Anixa Biosciences, Inc. (ANIX)

USD 2.38

(-4.42%)

Net Income Summary of Anixa Biosciences, Inc.

  • Anixa Biosciences, Inc.'s latest annual net income in 2023 was -9.81 Million USD , up 27.28% from previous year.
  • Anixa Biosciences, Inc.'s latest quarterly net income in 2024 Q3 was -3.27 Million USD , down -4.4% from previous quarter.
  • Anixa Biosciences, Inc. reported an annual net income of -13.49 Million USD in 2022, down -4.2% from previous year.
  • Anixa Biosciences, Inc. reported an annual net income of -12.94 Million USD in 2021, down -27.77% from previous year.
  • Anixa Biosciences, Inc. reported a quarterly net income of -3.13 Million USD for 2024 Q2, up 3.56% from previous quarter.
  • Anixa Biosciences, Inc. reported a quarterly net income of -3.25 Million USD for 2024 Q1, down -21.0% from previous quarter.

Annual Net Income Chart of Anixa Biosciences, Inc. (2023 - 1989)

Historical Annual Net Income of Anixa Biosciences, Inc. (2023 - 1989)

Year Net Income Net Income Growth
2023 -9.81 Million USD 27.28%
2022 -13.49 Million USD -4.2%
2021 -12.94 Million USD -27.77%
2020 -10.13 Million USD 15.52%
2019 -11.99 Million USD 14.3%
2018 -13.99 Million USD -179.42%
2017 -5 Million USD 0.15%
2016 -5.01 Million USD -263.76%
2015 -1.37 Million USD 85.64%
2014 -9.6 Million USD 4.7%
2013 -10.08 Million USD -137.02%
2012 -4.25 Million USD 42.36%
2011 -7.37 Million USD -42.57%
2010 -5.17 Million USD 68.61%
2009 -16.48 Million USD -183.24%
2008 -5.82 Million USD -6.66%
2007 -5.45 Million USD 28.19%
2006 -7.6 Million USD -70.76%
2005 -4.45 Million USD -32.45%
2004 -3.36 Million USD -7.91%
2003 -3.11 Million USD 5.2%
2002 -3.28 Million USD 8.03%
2001 -3.57 Million USD 28.05%
2000 -4.96 Million USD 41.6%
1999 -8.5 Million USD -19.72%
1998 -7.1 Million USD -22.41%
1997 -5.8 Million USD -7.41%
1996 -5.4 Million USD -80.0%
1995 -3 Million USD 11.76%
1994 -3.4 Million USD -21.43%
1993 -2.8 Million USD -55.56%
1992 -1.8 Million USD -38.46%
1991 -1.3 Million USD -18.18%
1990 -1.1 Million USD 0.0%
1989 -1.1 Million USD 15.38%

Peer Net Income Comparison of Anixa Biosciences, Inc.

Name Net Income Net Income Difference
Akebia Therapeutics, Inc. -51.92 Million USD 81.105%
Jaguar Health, Inc. -41.3 Million USD 76.245%
Keros Therapeutics, Inc. -152.99 Million USD 93.587%
Longboard Pharmaceuticals, Inc. -54.42 Million USD 81.972%
Alnylam Pharmaceuticals, Inc. -440.24 Million USD 97.771%
Ligand Pharmaceuticals Incorporated 52.15 Million USD 118.812%
ContextLogic Inc. -317 Million USD 96.905%
MiMedx Group, Inc. 67.43 Million USD 114.548%
MEI Pharma, Inc. 17.77 Million USD 155.186%
AlloVir, Inc. -190.41 Million USD 94.848%
Novavax, Inc. -545.06 Million USD 98.2%
Aptorum Group Limited -2.82 Million USD -247.335%
Ardelyx, Inc. -66.06 Million USD 85.15%
Arrowhead Pharmaceuticals, Inc. -205.27 Million USD 95.221%
Psyence Biomedical Ltd. -51.15 Million USD 80.823%
Vaxcyte, Inc. -402.26 Million USD 97.561%
Precigen, Inc. -95.9 Million USD 89.77%
Pharming Group N.V. -10.54 Million USD 6.987%
Phathom Pharmaceuticals, Inc. -201.59 Million USD 95.133%
Pieris Pharmaceuticals, Inc. -24.54 Million USD 60.025%
Rigel Pharmaceuticals, Inc. -25.09 Million USD 60.898%
Avidity Biosciences, Inc. -212.22 Million USD 95.377%
TransCode Therapeutics, Inc. -18.54 Million USD 47.099%
Reviva Pharmaceuticals Holdings, Inc. -24.33 Million USD 59.691%
Reviva Pharmaceuticals Holdings, Inc. -24.33 Million USD 59.691%
Bicycle Therapeutics plc -180.66 Million USD 94.569%
Sangamo Therapeutics, Inc. -257.83 Million USD 96.195%
Sol-Gel Technologies Ltd. -27.23 Million USD 63.98%
Acelyrin, Inc. -381.64 Million USD 97.429%
SELLAS Life Sciences Group, Inc. -37.34 Million USD 73.725%
Sensei Biotherapeutics, Inc. -34.1 Million USD 71.23%
Senti Biosciences, Inc. -92.91 Million USD 89.441%
Stoke Therapeutics, Inc. -104.69 Million USD 90.629%
AbCellera Biologics Inc. -146.39 Million USD 93.298%
Alaunos Therapeutics, Inc. -35.14 Million USD 72.08%
BioXcel Therapeutics, Inc. -179.05 Million USD 94.521%
Entrada Therapeutics, Inc. -6.68 Million USD -46.761%
Chimerix, Inc. -82.09 Million USD 88.049%
VistaGen Therapeutics, Inc. -29.36 Million USD 66.586%
Windtree Therapeutics, Inc. -20.29 Million USD 51.649%
Corbus Pharmaceuticals Holdings, Inc. -44.6 Million USD 78.004%
Viracta Therapeutics, Inc. -51.05 Million USD 80.785%
Elevation Oncology, Inc. -45.7 Million USD 78.534%
Alkermes plc 355.75 Million USD 102.758%
Fortress Biotech, Inc. -60.63 Million USD 83.82%
Fortress Biotech, Inc. -60.63 Million USD 83.82%
Agenus Inc. -245.76 Million USD 96.008%
HOOKIPA Pharma Inc. -81.58 Million USD 87.974%
Dyadic International, Inc. -6.79 Million USD -44.376%
ImmuCell Corporation -5.77 Million USD -69.899%
Eton Pharmaceuticals, Inc. -936 Thousand USD -948.184%
IDEAYA Biosciences, Inc. -112.96 Million USD 91.315%
Lantern Pharma Inc. -15.96 Million USD 38.533%
Immix Biopharma, Inc. -15.42 Million USD 36.4%
Incyte Corporation 597.59 Million USD 101.642%
IO Biotech, Inc. -86.08 Million USD 88.603%
Janux Therapeutics, Inc. -58.29 Million USD 83.17%
Inhibikase Therapeutics, Inc. -19.02 Million USD 48.442%
Outlook Therapeutics, Inc. -58.98 Million USD 83.366%
Syros Pharmaceuticals, Inc. -164.57 Million USD 94.039%
Kintara Therapeutics, Inc. -8.5 Million USD -15.41%
Barinthus Biotherapeutics plc -73.34 Million USD 86.624%
Madrigal Pharmaceuticals, Inc. -373.63 Million USD 97.374%
Sorrento Therapeutics, Inc. -572.84 Million USD 98.287%
NextCure, Inc. -62.72 Million USD 84.358%
Ocuphire Pharma, Inc. -9.98 Million USD 1.752%
Onconetix, Inc. -37.4 Million USD 73.774%
Oncternal Therapeutics, Inc. -39.47 Million USD 75.149%
Opthea Limited -220.24 Million USD 95.545%
PDS Biotechnology Corporation -42.94 Million USD 77.153%
PureTech Health plc -65.69 Million USD 85.066%
Pyxis Oncology, Inc. -73.79 Million USD 86.704%
Seer, Inc. -86.27 Million USD 88.628%
Salarius Pharmaceuticals, Inc. -12.54 Thousand USD -78120.86%
Clearside Biomedical, Inc. -32.48 Million USD 69.798%
Telomir Pharmaceuticals, Inc. Common Stock -13.07 Million USD 24.946%
VYNE Therapeutics Inc. -28.45 Million USD 65.517%
Wave Life Sciences Ltd. -57.51 Million USD 82.941%
Xeris Biopharma Holdings, Inc. -62.25 Million USD 84.241%
C4 Therapeutics, Inc. -132.49 Million USD 92.595%
ChromaDex Corporation -4.93 Million USD -98.684%
TRACON Pharmaceuticals, Inc. -3.58 Million USD -173.439%
Caribou Biosciences, Inc. -102.07 Million USD 90.388%
CRISPR Therapeutics AG -153.61 Million USD 93.613%
Precision BioSciences, Inc. -61.31 Million USD 84.0%
Fate Therapeutics, Inc. -160.92 Million USD 93.903%
Innoviva, Inc. 179.72 Million USD 105.459%
Summit Therapeutics Inc. -614.92 Million USD 98.405%
Verrica Pharmaceuticals Inc. -66.99 Million USD 85.356%
Aadi Bioscience, Inc. -65.76 Million USD 85.082%
ESSA Pharma Inc. -26.58 Million USD 63.092%
GlycoMimetics, Inc. -36.89 Million USD 73.412%
GT Biopharma, Inc. -7.59 Million USD -29.143%
Inhibrx Biosciences, Inc. -241.36 Million USD 95.935%
Catalyst Pharmaceuticals, Inc. 71.41 Million USD 113.739%
Orchestra BioMed Holdings, Inc. -49.12 Million USD 80.026%
Alzamend Neuro, Inc. -9.94 Million USD 1.375%
Rocket Pharmaceuticals, Inc. -245.59 Million USD 96.005%
Aptose Biosciences Inc. -51.2 Million USD 80.841%
ZyVersa Therapeutics, Inc. -98.29 Million USD 90.019%
Soligenix, Inc. -6.14 Million USD -59.769%
Century Therapeutics, Inc. -136.67 Million USD 92.822%
Kura Oncology, Inc. -152.63 Million USD 93.572%
TScan Therapeutics, Inc. -89.21 Million USD 89.003%
Intensity Therapeutics, Inc. -10.53 Million USD 6.899%
Ocean Biomedical, Inc. 565.47 Thousand USD 1835.017%
CytomX Therapeutics, Inc. -569 Thousand USD -1624.253%
Autolus Therapeutics plc -208.38 Million USD 95.292%
Mineralys Therapeutics, Inc. -71.89 Million USD 86.354%
EyePoint Pharmaceuticals, Inc. -70.79 Million USD 86.142%
Eterna Therapeutics Inc. -21.66 Million USD 54.721%
Adaptive Biotechnologies Corporation -225.25 Million USD 95.644%
GRI Bio, Inc. -13.03 Million USD 24.745%
Xenetic Biosciences, Inc. -4.13 Million USD -137.291%
Tenaya Therapeutics, Inc. -124.08 Million USD 92.093%
IGM Biosciences, Inc. -246.41 Million USD 96.019%
INmune Bio, Inc. -30 Million USD 67.305%
Heron Therapeutics, Inc. -110.55 Million USD 91.126%
SAB Biotherapeutics, Inc. -42.19 Million USD 76.748%
Pasithea Therapeutics Corp. -15.96 Million USD 38.534%
Entero Therapeutics, Inc. -15.79 Million USD 37.885%
Milestone Pharmaceuticals Inc. -59.68 Million USD 83.562%
X4 Pharmaceuticals, Inc. -101.16 Million USD 90.302%
Atara Biotherapeutics, Inc. -276.12 Million USD 96.447%
Coherus BioSciences, Inc. -237.89 Million USD 95.876%
Verastem, Inc. -87.36 Million USD 88.77%
Abeona Therapeutics Inc. -54.18 Million USD 81.895%
Pliant Therapeutics, Inc. -161.33 Million USD 93.919%
Tonix Pharmaceuticals Holding Corp. -116.65 Million USD 91.59%
Histogen Inc. -10.62 Million USD 7.626%
Aprea Therapeutics, Inc. -14.28 Million USD 31.328%
Surrozen, Inc. -43.04 Million USD 77.206%
Organovo Holdings, Inc. -14.67 Million USD 33.127%
Lixte Biotechnology Holdings, Inc. -5.08 Million USD -92.863%
Ovid Therapeutics Inc. -52.33 Million USD 81.255%
Panbela Therapeutics, Inc. -25.26 Million USD 61.165%
CASI Pharmaceuticals, Inc. -26.93 Million USD 63.579%
Cadrenal Therapeutics, Inc. Common Stock -8.35 Million USD -17.397%
Centessa Pharmaceuticals plc -151.08 Million USD 93.506%
Hepion Pharmaceuticals, Inc. -48.92 Million USD 79.947%
Arcturus Therapeutics Holdings Inc. -29.72 Million USD 66.994%
BioRestorative Therapies, Inc. -10.41 Million USD 5.824%
Apollomics, Inc. -172.6 Million USD 94.316%
Amarin Corporation plc -59.11 Million USD 83.403%
Mesoblast Limited -87.95 Million USD 88.846%
Turnstone Biologics Corp. -55.2 Million USD 82.226%
Kymera Therapeutics, Inc. -146.96 Million USD 93.324%
Synaptogenix, Inc. -6.03 Million USD -62.474%
Tiziana Life Sciences Ltd -16.2 Million USD 39.468%
Aurinia Pharmaceuticals Inc. -78.02 Million USD 87.425%
BriaCell Therapeutics Corp. -4.79 Million USD -104.76%
Monopar Therapeutics Inc. -8.4 Million USD -16.767%
Exelixis, Inc. 207.76 Million USD 104.722%
Better Therapeutics, Inc. -39.76 Million USD 75.324%
Nurix Therapeutics, Inc. -143.94 Million USD 93.184%
Apellis Pharmaceuticals, Inc. -528.62 Million USD 98.144%
NLS Pharmaceutics AG -12.17 Million USD 19.397%
Dermata Therapeutics, Inc. -7.79 Million USD -25.868%
Aridis Pharmaceuticals, Inc. -30.74 Million USD 68.093%
Gritstone bio, Inc. -138.49 Million USD 92.916%
Jasper Therapeutics, Inc. -64.46 Million USD 84.781%
TNF Pharmaceuticals, Inc. -3.99 Million USD -145.278%
Avid Bioservices, Inc. -140.75 Million USD 93.03%
Insmed Incorporated -749.56 Million USD 98.691%
Virpax Pharmaceuticals, Inc. -15.18 Million USD 35.409%
MediWound Ltd. -6.71 Million USD -46.084%
OmniAb, Inc. -50.61 Million USD 80.618%
Alector, Inc. -130.39 Million USD 92.476%
Seres Therapeutics, Inc. -113.72 Million USD 91.373%
Checkpoint Therapeutics, Inc. -51.84 Million USD 81.077%
Zai Lab Limited -334.62 Million USD 97.068%
Revance Therapeutics, Inc. -323.98 Million USD 96.972%
Aura Biosciences, Inc. -76.4 Million USD 87.16%
Lyell Immunopharma, Inc. -234.63 Million USD 95.819%
Immunic, Inc. -93.61 Million USD 89.52%
Tarsus Pharmaceuticals, Inc. -135.89 Million USD 92.78%
Veracyte, Inc. -74.4 Million USD 86.814%
InMed Pharmaceuticals Inc. -7.67 Million USD -27.821%
FibroGen, Inc. -284.23 Million USD 96.548%
SeaStar Medical Holding Corporation -26.23 Million USD 62.599%
Adial Pharmaceuticals, Inc. -7 Million USD -40.119%
Sonnet BioTherapeutics Holdings, Inc. -18.83 Million USD 47.904%
Jazz Pharmaceuticals plc 414.83 Million USD 102.365%
Cyclacel Pharmaceuticals, Inc. -22.55 Million USD 56.502%
Amylyx Pharmaceuticals, Inc. 49.27 Million USD 119.912%
TG Therapeutics, Inc. 12.67 Million USD 177.423%
Galecto, Inc. -38.34 Million USD 74.417%
Calithera Biosciences, Inc. -18.86 Million USD 47.996%
Fortrea Holdings Inc. -3.4 Million USD -188.559%
KalVista Pharmaceuticals, Inc. -126.64 Million USD 92.253%
Aptevo Therapeutics Inc. -17.41 Million USD 43.651%
XBiotech Inc. -24.55 Million USD 60.048%
Jasper Therapeutics, Inc. -64.46 Million USD 84.781%
Lyra Therapeutics, Inc. -62.68 Million USD 84.347%
Foghorn Therapeutics Inc. -98.42 Million USD 90.032%
Y-mAbs Therapeutics, Inc. -21.42 Million USD 54.212%
Theravance Biopharma, Inc. -55.19 Million USD 82.224%
Ultragenyx Pharmaceutical Inc. -606.63 Million USD 98.383%
Metagenomi, Inc. Common Stock -68.25 Million USD 85.626%
Vaxxinity, Inc. -56.93 Thousand USD -17132.234%
BioCryst Pharmaceuticals, Inc. -226.53 Million USD 95.669%
Gain Therapeutics, Inc. -22.26 Million USD 55.94%
Cartesian Therapeutics, Inc. -219.71 Million USD 95.535%
NexImmune, Inc. -32.34 Million USD 69.667%
Creative Medical Technology Holdings, Inc. -5.28 Million USD -85.583%
Marker Therapeutics, Inc. -14.04 Million USD 30.15%
Regeneron Pharmaceuticals, Inc. 3.95 Billion USD 100.248%
Chemomab Therapeutics Ltd. -24.22 Million USD 59.494%
Scopus BioPharma Inc. -11.6 Million USD 15.494%
RAPT Therapeutics, Inc. -116.79 Million USD 91.6%
Ainos, Inc. -13.77 Million USD 28.754%
Pluri Inc. -20.88 Million USD 53.03%
Prothena Corporation plc -147.02 Million USD 93.327%
Adaptimmune Therapeutics plc -113.87 Million USD 91.384%
Celularity Inc. -196.29 Million USD 95.002%
Rallybio Corporation -74.56 Million USD 86.842%
Cue Biopharma, Inc. -50.73 Million USD 80.662%
MeiraGTx Holdings plc -84.02 Million USD 88.324%
Omeros Corporation -117.81 Million USD 91.672%
Humacyte, Inc. -110.77 Million USD 91.143%
Immunocore Holdings plc -55.28 Million USD 82.254%
Cocrystal Pharma, Inc. -17.98 Million USD 45.446%
Cidara Therapeutics, Inc. -22.93 Million USD 57.215%
Blueprint Medicines Corporation -506.98 Million USD 98.065%
CalciMedica, Inc. -34.35 Million USD 71.444%
Cabaletta Bio, Inc. -67.67 Million USD 85.503%
Marinus Pharmaceuticals, Inc. -141.4 Million USD 93.062%
Scholar Rock Holding Corporation -165.78 Million USD 94.082%
Sana Biotechnology, Inc. -283.25 Million USD 96.536%
Pulmatrix, Inc. -14.12 Million USD 30.522%
Elicio Therapeutics, Inc. -35.19 Million USD 72.124%
Vigil Neuroscience, Inc. -82.63 Million USD 88.128%
Intellia Therapeutics, Inc. -481.19 Million USD 97.961%
Adlai Nortye Ltd. American Depositary Shares -104.87 Million USD 90.645%
Cytokinetics, Incorporated -526.24 Million USD 98.136%
Eloxx Pharmaceuticals, Inc. -36.06 Million USD 72.796%
Nutriband Inc. -5.48 Million USD -78.859%
Protara Therapeutics, Inc. -40.42 Million USD 75.727%
Vor Biopharma Inc. -117.86 Million USD 91.676%
Roivant Sciences Ltd. 4.34 Billion USD 100.226%
Evogene Ltd. -23.87 Million USD 58.914%
ProKidney Corp. -35.46 Million USD 72.338%
Applied Therapeutics, Inc. -119.76 Million USD 91.808%
Hoth Therapeutics, Inc. -7.84 Million USD -25.054%
BridgeBio Pharma, Inc. -643.2 Million USD 98.475%
CorMedix Inc. -46.33 Million USD 78.828%
BioLineRx Ltd. -60.61 Million USD 83.814%
Tango Therapeutics, Inc. -101.74 Million USD 90.357%
Galectin Therapeutics Inc. -41.06 Million USD 76.109%
Atai Life Sciences N.V. -40.22 Million USD 75.609%
Renovaro Biosciences Inc. -80.65 Million USD 87.835%
Aerovate Therapeutics, Inc. -75.52 Million USD 87.009%
Zentalis Pharmaceuticals, Inc. -292.19 Million USD 96.642%
Sagimet Biosciences Inc. -27.87 Million USD 64.805%
MediciNova, Inc. -8.57 Million USD -14.46%
Praxis Precision Medicines, Inc. -123.27 Million USD 92.042%
Cardio Diagnostics Holdings, Inc. -8.37 Million USD -17.121%
GeoVax Labs, Inc. -25.96 Million USD 62.217%
Axsome Therapeutics, Inc. -239.23 Million USD 95.899%
Biomea Fusion, Inc. -117.25 Million USD 91.633%
PTC Therapeutics, Inc. -626.6 Million USD 98.434%
Mereo BioPharma Group plc -29.46 Million USD 66.704%
Cullinan Oncology, Inc. -153.16 Million USD 93.594%
Syndax Pharmaceuticals, Inc. -209.36 Million USD 95.314%
Absci Corporation -110.56 Million USD 91.127%
NRx Pharmaceuticals, Inc. -30.15 Million USD 67.459%
4D Molecular Therapeutics, Inc. -100.83 Million USD 90.27%
Dyne Therapeutics, Inc. -235.93 Million USD 95.842%
Kiniksa Pharmaceuticals, Ltd. 14.08 Million USD 169.661%
Ventyx Biosciences, Inc. -192.96 Million USD 94.916%
Allakos Inc. -185.7 Million USD 94.717%
Imunon, Inc. -19.51 Million USD 49.726%
Fulcrum Therapeutics, Inc. -97.33 Million USD 89.92%
Corcept Therapeutics Incorporated 106.14 Million USD 109.243%
BioAtla, Inc. -123.46 Million USD 92.053%
NLS Pharmaceutics AG -12.17 Million USD 19.397%
Bio-Path Holdings, Inc. -16.07 Million USD 38.979%
Allogene Therapeutics, Inc. -327.26 Million USD 97.002%
Larimar Therapeutics, Inc. -36.94 Million USD 73.447%
XOMA Corporation -40.83 Million USD 75.972%
Kezar Life Sciences, Inc. -101.87 Million USD 90.369%
Cara Therapeutics, Inc. -118.51 Million USD 91.722%
aTyr Pharma, Inc. -50.38 Million USD 80.529%
Aligos Therapeutics, Inc. -87.67 Million USD 88.81%
Akero Therapeutics, Inc. -151.75 Million USD 93.535%
Viridian Therapeutics, Inc. -237.73 Million USD 95.873%
Eliem Therapeutics, Inc. -35.11 Million USD 72.064%
EyeGate Pharmaceuticals, Inc. -8.09 Million USD -21.244%
Akari Therapeutics, Plc -10 Million USD 1.968%
Tevogen Bio Holdings Inc. -67.32 Thousand USD -14472.596%
Halozyme Therapeutics, Inc. 281.59 Million USD 103.484%
Lexaria Bioscience Corp. -6.66 Million USD -47.204%
UroGen Pharma Ltd. -102.24 Million USD 90.404%
Sutro Biopharma, Inc. -106.79 Million USD 90.813%
ZIVO Bioscience, Inc. -7.77 Million USD -26.151%
Orgenesis Inc. -55.36 Million USD 82.278%
Entera Bio Ltd. -8.88 Million USD -10.372%
GH Research PLC -35.58 Million USD 72.431%
Lisata Therapeutics, Inc. -20.84 Million USD 52.922%
Reneo Pharmaceuticals, Inc. -77.38 Million USD 87.322%
Xencor, Inc. -126.08 Million USD 92.219%
60 Degrees Pharmaceuticals, Inc. -3.76 Million USD -160.536%
Replimune Group, Inc. -215.79 Million USD 95.454%
Coeptis Therapeutics Holdings, Inc. -21.26 Million USD 53.866%
Vanda Pharmaceuticals Inc. 2.5 Million USD 491.032%
Lexaria Bioscience Corp. -6.66 Million USD -47.204%
Portage Biotech Inc. -75.33 Million USD 86.978%
Cardio Diagnostics Holdings, Inc. -8.37 Million USD -17.121%
Olema Pharmaceuticals, Inc. -96.65 Million USD 89.849%
OncoCyte Corporation -27.78 Million USD 64.684%
Qualigen Therapeutics, Inc. -13.41 Million USD 26.878%
Processa Pharmaceuticals, Inc. -11.12 Million USD 11.784%
Purple Biotech Ltd. -19.88 Million USD 50.649%
CollPlant Biotechnologies Ltd. -7.01 Million USD -39.778%
scPharmaceuticals Inc. -54.81 Million USD 82.1%
ProMIS Neurosciences, Inc. -17.5 Million USD 43.957%
HilleVax, Inc. -123.56 Million USD 92.06%
NeuroSense Therapeutics Ltd. -10.1 Million USD 2.929%
Tharimmune, Inc. -9.31 Million USD -5.278%
Genprex, Inc. -30.86 Million USD 68.209%
Neumora Therapeutics, Inc. Common Stock -235.92 Million USD 95.841%
Atossa Therapeutics, Inc. -30.09 Million USD 67.399%
XTL Biopharmaceuticals Ltd. -1.78 Million USD -450.561%
Virios Therapeutics, Inc. -5.29 Million USD -85.252%
OKYO Pharma Limited -16.82 Thousand USD -58210.441%
Savara Inc. -54.69 Million USD 82.063%
Curis, Inc. -47.41 Million USD 79.307%
Daré Bioscience, Inc. -30.16 Million USD 67.472%
Carmell Therapeutics Corporation -15.44 Million USD 36.478%
Titan Pharmaceuticals, Inc. -5.56 Million USD -76.172%
Achieve Life Sciences, Inc. -29.81 Million USD 67.094%
BeiGene, Ltd. -881.7 Million USD 98.887%
Kiromic BioPharma, Inc. -21.29 Million USD 53.926%
Revolution Medicines, Inc. Warrant -436.36 Million USD 97.752%
Protagonist Therapeutics, Inc. -78.95 Million USD 87.574%
Erasca, Inc. -125.04 Million USD 92.154%
bluebird bio, Inc. -211.91 Million USD 95.37%
Protagenic Therapeutics, Inc. -5 Million USD -96.2%
BioMarin Pharmaceutical Inc. 167.64 Million USD 105.852%
DBV Technologies S.A. -72.72 Million USD 86.51%
Protagenic Therapeutics, Inc. -5 Million USD -96.2%
Moderna, Inc. -4.71 Billion USD 99.792%
Vincerx Pharma, Inc. -40.15 Million USD 75.568%
Fresh Tracks Therapeutics, Inc. -5.69 Million USD -72.304%
Molecular Templates, Inc. -8.12 Million USD -20.766%
Acrivon Therapeutics, Inc. Common Stock -60.38 Million USD 83.753%
Travere Therapeutics, Inc. -111.39 Million USD 91.193%
Monte Rosa Therapeutics, Inc. -135.35 Million USD 92.751%
Spruce Biosciences, Inc. -47.91 Million USD 79.526%
Celldex Therapeutics, Inc. -141.42 Million USD 93.063%
Cogent Biosciences, Inc. -192.41 Million USD 94.901%
MacroGenics, Inc. -9.05 Million USD -8.313%
RenovoRx, Inc. -10.23 Million USD 4.115%
Adicet Bio, Inc. -142.65 Million USD 93.123%
Prime Medicine, Inc. -198.13 Million USD 95.048%
Aditxt, Inc. -32.38 Million USD 69.701%
Adagene Inc. -18.94 Million USD 48.217%
Estrella Immunopharma, Inc. -7.31 Million USD -34.182%
Quantum-Si incorporated -95.96 Million USD 89.776%
Maravai LifeSciences Holdings, Inc. -119.02 Million USD 91.757%
Acurx Pharmaceuticals, Inc. -14.57 Million USD 32.699%
Voyager Therapeutics, Inc. 132.33 Million USD 107.414%
SciSparc Ltd. -5.12 Million USD -91.546%
Vericel Corporation -3.18 Million USD -208.328%
Revelation Biosciences, Inc. -120.25 Thousand USD -8058.564%
Minerva Neurosciences, Inc. -30 Million USD 67.303%
Generation Bio Co. -126.61 Million USD 92.251%
Astria Therapeutics, Inc. -72.89 Million USD 86.54%
Black Diamond Therapeutics, Inc. -82.44 Million USD 88.1%
Arcutis Biotherapeutics, Inc. -262.14 Million USD 96.257%
Invivyd, Inc. -198.64 Million USD 95.061%
Relay Therapeutics, Inc. -341.97 Million USD 97.131%
Quoin Pharmaceuticals, Ltd. -8.68 Million USD -12.944%
Spero Therapeutics, Inc. 22.8 Million USD 143.019%
Artelo Biosciences, Inc. -9.87 Million USD 0.638%
2seventy bio, Inc. -217.57 Million USD 95.491%
ADMA Biologics, Inc. -28.23 Million USD 65.257%
Clene Inc. -49.5 Million USD 80.181%
Capricor Therapeutics, Inc. -22.28 Million USD 55.98%
Boundless Bio, Inc. Common Stock -49.43 Million USD 80.153%
GeoVax Labs, Inc. -25.96 Million USD 62.217%
Recursion Pharmaceuticals, Inc. -328.06 Million USD 97.009%
Citius Pharmaceuticals, Inc. -32.54 Million USD 69.852%
Contineum Therapeutics, Inc. Class A Common Stock 22.72 Million USD 143.182%
Relmada Therapeutics, Inc. -98.79 Million USD 90.069%
Finch Therapeutics Group, Inc. -74.75 Million USD 86.876%
ALX Oncology Holdings Inc. -160.8 Million USD 93.899%
Vir Biotechnology, Inc. -615.06 Million USD 98.405%
Evaxion Biotech A/S -22.12 Million USD 55.656%
Ocular Therapeutix, Inc. -80.73 Million USD 87.848%
Verve Therapeutics, Inc. -200.06 Million USD 95.096%
Trevena, Inc. -40.28 Million USD 75.648%
Surrozen, Inc. -43.04 Million USD 77.206%
Tyra Biosciences, Inc. -69.13 Million USD 85.809%
Cingulate Inc. -23.53 Million USD 58.313%
Galmed Pharmaceuticals Ltd. -6.91 Million USD -41.942%
Unity Biotechnology, Inc. -39.86 Million USD 75.386%
Tenax Therapeutics, Inc. -7.71 Million USD -27.239%
Terns Pharmaceuticals, Inc. -90.21 Million USD 89.124%
ACADIA Pharmaceuticals Inc. -61.28 Million USD 83.991%
Connect Biopharma Holdings Limited -59.5 Million USD 83.512%
Clearmind Medicine Inc. -11.95 Million USD 17.934%
Kronos Bio, Inc. -112.67 Million USD 91.293%
Bolt Biotherapeutics, Inc. -69.19 Million USD 85.822%
CERo Therapeutics Holdings, Inc. -2536.23 USD -386734.002%
Viking Therapeutics, Inc. -85.89 Million USD 88.578%
Statera Biopharma, Inc. -174.4 Million USD 94.375%
ImmunityBio, Inc. -583.19 Million USD 98.318%
Korro Bio, Inc. -81.17 Million USD 87.913%
Kineta, Inc. -14.09 Million USD 30.414%
BioVie Inc. -32.12 Million USD 69.456%
Codexis, Inc. -76.24 Million USD 87.131%
Celularity Inc. -196.29 Million USD 95.002%
Crinetics Pharmaceuticals, Inc. -214.52 Million USD 95.427%
Celcuity Inc. -63.77 Million USD 84.617%
Virax Biolabs Group Limited -6.73 Million USD -45.704%
Cibus, Inc. -267.62 Million USD 96.334%
Eledon Pharmaceuticals, Inc. -40.32 Million USD 75.671%
eFFECTOR Therapeutics, Inc. -35.81 Million USD 72.603%
IN8bio, Inc. -30 Million USD 67.304%
Kodiak Sciences Inc. -260.49 Million USD 96.234%
Annexon, Inc. -134.23 Million USD 92.691%
Adverum Biotechnologies, Inc. -117.16 Million USD 91.626%
Assembly Biosciences, Inc. -61.22 Million USD 83.976%
Avalo Therapeutics, Inc. -31.54 Million USD 68.897%
Ionis Pharmaceuticals, Inc. -366.28 Million USD 97.321%
Eyenovia, Inc. -27.26 Million USD 64.011%
Puma Biotechnology, Inc. 21.59 Million USD 145.44%
Conduit Pharmaceuticals Inc. -535 Thousand USD -1733.832%
Xilio Therapeutics, Inc. -76.4 Million USD 87.159%
Arcellx, Inc. -70.69 Million USD 86.121%
Cardiff Oncology, Inc. -41.44 Million USD 76.325%
Enanta Pharmaceuticals, Inc. -133.81 Million USD 92.668%
Regulus Therapeutics Inc. -30.03 Million USD 67.337%
Moolec Science SA -51.78 Million USD 81.056%
Acumen Pharmaceuticals, Inc. -52.37 Million USD 81.266%
Geron Corporation -184.12 Million USD 94.672%
LAVA Therapeutics N.V. -41.97 Million USD 76.626%
Royalty Pharma plc 1.13 Billion USD 100.865%
Atea Pharmaceuticals, Inc. -135.95 Million USD 92.784%
Greenwich LifeSciences, Inc. -8.89 Million USD -10.338%
TFF Pharmaceuticals, Inc. -21.24 Million USD 53.816%
Mersana Therapeutics, Inc. -171.67 Million USD 94.285%
Humacyte, Inc. -110.77 Million USD 91.143%
Structure Therapeutics Inc. -89.62 Million USD 89.053%
89bio, Inc. -142.18 Million USD 93.1%
PMV Pharmaceuticals, Inc. -68.96 Million USD 85.773%
Avenue Therapeutics, Inc. -10.37 Million USD 5.454%
Genelux Corporation -28.29 Million USD 65.328%
Trevi Therapeutics, Inc. -29.06 Million USD 66.245%
Lexicon Pharmaceuticals, Inc. -177.11 Million USD 94.461%
Notable Labs, Ltd. -11.26 Million USD 12.9%
Liquidia Corporation -78.5 Million USD 87.502%
Mustang Bio, Inc. -51.6 Million USD 80.987%
Immunovant, Inc. -259.33 Million USD 96.217%
Quantum-Si incorporated -95.96 Million USD 89.776%
Arbutus Biopharma Corporation -72.84 Million USD 86.532%
DiaMedica Therapeutics Inc. -19.38 Million USD 49.378%
Vera Therapeutics, Inc. -95.99 Million USD 89.779%
Acasti Pharma Inc. -12.85 Million USD 23.668%
MiNK Therapeutics, Inc. -22.45 Million USD 56.314%
Pasithea Therapeutics Corp. -15.96 Million USD 38.534%
Xenon Pharmaceuticals Inc. -182.39 Million USD 94.621%
Elevai Labs, Inc. Common Stock -4.3 Million USD -128.082%
NeuroBo Pharmaceuticals, Inc. -12.47 Million USD 21.323%
Tempest Therapeutics, Inc. -29.49 Million USD 66.732%
Soleno Therapeutics, Inc. -38.98 Million USD 74.836%
PepGen Inc. -78.62 Million USD 87.522%
Moleculin Biotech, Inc. -29.76 Million USD 67.043%
United Therapeutics Corporation 984.8 Million USD 100.996%
Nuvectis Pharma, Inc. -22.26 Million USD 55.925%
Solid Biosciences Inc. -96.01 Million USD 89.782%
BriaCell Therapeutics Corp. -4.79 Million USD -104.76%
Immuneering Corporation -53.47 Million USD 81.652%
Lixte Biotechnology Holdings, Inc. -5.08 Million USD -92.863%
Silo Pharma, Inc. -3.7 Million USD -165.113%
Belite Bio, Inc -31.63 Million USD 68.984%
XOMA Corporation -40.83 Million USD 75.972%
ARS Pharmaceuticals, Inc. -54.36 Million USD 81.953%
Bionomics Limited -15.49 Billion USD 99.937%
Apogee Therapeutics, Inc. -83.98 Million USD 88.318%
Alpha Tau Medical Ltd. -29.15 Million USD 66.351%
uniQure N.V. -308.47 Million USD 96.82%
Cassava Sciences, Inc. -97.21 Million USD 89.908%
Estrella Immunopharma, Inc. -7.31 Million USD -34.182%
Poseida Therapeutics, Inc. -123.43 Million USD 92.051%
Forte Biosciences, Inc. -31.47 Million USD 68.83%
Anebulo Pharmaceuticals, Inc. -8.2 Million USD -19.621%
Enlivex Therapeutics Ltd. -29.06 Million USD 66.248%
Conduit Pharmaceuticals Inc. -535 Thousand USD -1733.832%
SeaStar Medical Holding Corporation -26.23 Million USD 62.599%
FibroBiologics, Inc. Common Stock -16.48 Million USD 40.485%
Altimmune, Inc. -88.44 Million USD 88.907%
Amicus Therapeutics, Inc. -151.58 Million USD 93.528%
Alpha Tau Medical Ltd. -29.15 Million USD 66.351%
Compugen Ltd. -18.75 Million USD 47.686%
Peak Bio, Inc. -1259.26 USD -779008.365%
Zevra Therapeutics, Inc. -46.04 Million USD 78.694%
Benitec Biopharma Inc. -21.75 Million USD 54.894%
Spyre Therapeutics, Inc. -338.79 Million USD 97.104%
NKGen Biotech, Inc. Common Stock -82.95 Million USD 88.173%
Zura Bio Limited -60.36 Million USD 83.746%
PolyPid Ltd. -23.86 Million USD 58.89%
Aileron Therapeutics, Inc. -15.73 Million USD 37.637%
NKGen Biotech, Inc. Warrants -82.95 Million USD 88.173%
Instil Bio, Inc. -156.08 Million USD 93.714%
argenx SE -295.05 Million USD 96.675%
Immunome, Inc. -106.8 Million USD 90.814%
Compass Therapeutics, Inc. -42.49 Million USD 76.912%
Verona Pharma plc -54.36 Million USD 81.955%
enGene Holdings Inc. Warrants -99.91 Million USD 90.181%
Shattuck Labs, Inc. -87.29 Million USD 88.761%
CervoMed Inc. -2.17 Million USD -351.73%
LENZ Therapeutics, Inc. -124.65 Million USD 92.129%
Plus Therapeutics, Inc. -13.31 Million USD 26.322%
Dianthus Therapeutics, Inc. -43.55 Million USD 77.474%
Moolec Science SA -51.78 Million USD 81.056%
Enveric Biosciences, Inc. -17.29 Thousand USD -56638.105%
Inovio Pharmaceuticals, Inc. -135.11 Million USD 92.739%
AnaptysBio, Inc. -163.61 Million USD 94.004%
Design Therapeutics, Inc. -66.86 Million USD 85.326%
Leap Therapeutics, Inc. -81.41 Million USD 87.949%
NeurAxis, Inc. -14.62 Million USD 32.924%
Seelos Therapeutics, Inc. -37.88 Million USD 74.101%
Lumos Pharma, Inc. -34.03 Million USD 71.173%
Achilles Therapeutics plc -69.66 Million USD 85.917%
enGene Holdings Inc. Common Stock -99.91 Million USD 90.181%
180 Life Sciences Corp. -19.93 Million USD 50.785%
Opiant Pharmaceuticals, Inc. 3 Million USD 426.078%
CERo Therapeutics Holdings, Inc. -2536.23 USD -386734.002%
Nutriband Inc. -5.48 Million USD -78.859%
ORIC Pharmaceuticals, Inc. -100.69 Million USD 90.257%
CG Oncology, Inc. Common stock -48.6 Million USD 79.816%
Fractyl Health, Inc. Common Stock -77.09 Million USD 87.273%
Rani Therapeutics Holdings, Inc. -33.97 Million USD 71.119%
MoonLake Immunotherapeutics -36 Million USD 72.753%
Palisade Bio, Inc. -12.3 Million USD 20.236%
Tourmaline Bio, Inc. -42.12 Million USD 76.709%
Beam Therapeutics Inc. -132.52 Million USD 92.597%
Neurogene Inc. -36.31 Million USD 72.985%
Mirum Pharmaceuticals, Inc. -163.41 Million USD 93.996%
AEON Biopharma, Inc. -52.55 Million USD 81.332%
CARGO Therapeutics, Inc. Common Stock -98.14 Million USD 90.004%
Sesen Bio, Inc. -19.88 Million USD 50.659%
Enliven Therapeutics, Inc. -71.58 Million USD 86.294%
Kiora Pharmaceuticals, Inc. -12.51 Million USD 21.599%
Iovance Biotherapeutics, Inc. -444.03 Million USD 97.79%
Taysha Gene Therapies, Inc. -111.56 Million USD 91.206%
Athira Pharma, Inc. -117.67 Million USD 91.662%
Vaccinex, Inc. -20.25 Million USD 51.553%
HCW Biologics Inc. -24.99 Million USD 60.747%
XOMA Corporation -40.83 Million USD 75.972%
Nektar Therapeutics -276.05 Million USD 96.446%
Arvinas, Inc. -367.3 Million USD 97.329%
Tevogen Bio Holdings Inc. -67.32 Thousand USD -14472.596%
Merus N.V. -154.93 Million USD 93.668%
Omega Therapeutics, Inc. -97.42 Million USD 89.93%
Quince Therapeutics, Inc. -31.38 Million USD 68.74%
Rezolute, Inc. -68.45 Million USD 85.669%
Clene Inc. -49.5 Million USD 80.181%
Indaptus Therapeutics, Inc. -15.42 Million USD 36.389%
BeyondSpring Inc. -21.02 Million USD 53.339%
Synlogic, Inc. -57.28 Million USD 82.872%
Allarity Therapeutics, Inc. -11.9 Million USD 17.562%
Phio Pharmaceuticals Corp. -10.82 Million USD 9.376%
Peak Bio, Inc. -1259.26 USD -779008.365%
Werewolf Therapeutics, Inc. -37.36 Million USD 73.745%
Krystal Biotech, Inc. 10.93 Million USD 189.746%
Karyopharm Therapeutics Inc. -143.09 Million USD 93.144%
SpringWorks Therapeutics, Inc. -325.1 Million USD 96.982%
Lipella Pharmaceuticals Inc. -4.61 Million USD -112.407%
MannKind Corporation -11.93 Million USD 17.817%
Ikena Oncology, Inc. -68.16 Million USD 85.607%
Cyclerion Therapeutics, Inc. -21.01 Million USD 53.314%
Gyre Therapeutics, Inc. -92.93 Million USD 89.443%
Gossamer Bio, Inc. -179.81 Million USD 94.544%
CohBar, Inc. -11.96 Million USD 17.983%
Cognition Therapeutics, Inc. -25.78 Million USD 61.955%
NRx Pharmaceuticals, Inc. -30.15 Million USD 67.459%
Legend Biotech Corporation -518.25 Million USD 98.107%
Mural Oncology plc -207.44 Million USD 95.271%
Biora Therapeutics, Inc. -124.11 Million USD 92.095%
PaxMedica, Inc. Common Stock -18.28 Million USD 46.358%
Disc Medicine, Inc. -76.42 Million USD 87.163%
Champions Oncology, Inc. -7.27 Million USD -34.841%
REGENXBIO Inc. -263.49 Million USD 96.277%
Ensysce Biosciences, Inc. -10.61 Million USD 7.557%
Anavex Life Sciences Corp. -47.5 Million USD 79.347%
Cellectar Biosciences, Inc. -37.98 Million USD 74.17%
Edgewise Therapeutics, Inc. -100.16 Million USD 90.205%
Vaxart, Inc. -82.46 Million USD 88.103%
PharmaCyte Biotech, Inc. 333.76 Thousand USD 3039.511%
Aldeyra Therapeutics, Inc. -37.54 Million USD 73.867%
Cellectis S.A. -101.05 Million USD 90.292%
Longeveron Inc. -21.41 Million USD 54.182%
Repare Therapeutics Inc. -93.79 Million USD 89.54%
Sarepta Therapeutics, Inc. -535.97 Million USD 98.17%
Inozyme Pharma, Inc. -71.16 Million USD 86.215%
Revolution Medicines, Inc. -436.36 Million USD 97.752%
Nymox Pharmaceutical Corporation -6.57 Million USD -49.308%
Third Harmonic Bio, Inc. -30.82 Million USD 68.171%
ArriVent BioPharma, Inc. Common Stock -69.33 Million USD 85.849%
AN2 Therapeutics, Inc. -64.73 Million USD 84.844%
Vertex Pharmaceuticals Incorporated 3.61 Billion USD 100.271%
Denali Therapeutics Inc. -145.22 Million USD 93.244%
Revelation Biosciences, Inc. -120.25 Thousand USD -8058.564%
Veru Inc. -93.15 Million USD 89.468%
Corvus Pharmaceuticals, Inc. -27.02 Million USD 63.702%
Cingulate Inc. -23.53 Million USD 58.313%
Passage Bio, Inc. -102.06 Million USD 90.387%
Context Therapeutics Inc. -23.96 Million USD 59.06%
Exicure, Inc. -16.91 Million USD 41.995%
Day One Biopharmaceuticals, Inc. -188.91 Million USD 94.807%
Oramed Pharmaceuticals Inc. -37.76 Million USD 74.02%
Scinai Immunotherapeutics Ltd. -6.5 Million USD -50.769%
Rhythm Pharmaceuticals, Inc. -184.67 Million USD 94.688%
Nuvalent, Inc. -126.21 Million USD 92.227%
ABVC BioPharma, Inc. -10.51 Million USD 6.701%
Carisma Therapeutics, Inc. -86.87 Million USD 88.707%
Unicycive Therapeutics, Inc. -30.54 Million USD 67.879%
OmniAb, Inc. -50.61 Million USD 80.618%
Anew Medical, Inc. 1.34 Million USD 828.833%
Fennec Pharmaceuticals Inc. -16.04 Million USD 38.853%
Lipocine Inc. -16.35 Million USD 40.002%
Lexeo Therapeutics, Inc. Common Stock -66.39 Million USD 85.223%
Nautilus Biotechnology, Inc. -63.67 Million USD 84.592%
SAB Biotherapeutics, Inc. -42.19 Million USD 76.748%
G1 Therapeutics, Inc. -47.96 Million USD 79.546%
Bellerophon Therapeutics, Inc. -19.83 Million USD 50.527%
Sage Therapeutics, Inc. -541.48 Million USD 98.188%
Ocugen, Inc. -63.07 Million USD 84.446%
Mind Medicine (MindMed) Inc. -95.73 Million USD 89.752%
Q32 Bio Inc. -112.96 Million USD 91.315%
Brainstorm Cell Therapeutics Inc. -17.19 Million USD 42.933%
Alumis Inc. Common Stock -154.99 Million USD 93.67%
Equillium, Inc. -13.33 Million USD 26.427%
Kyverna Therapeutics, Inc. -60.36 Million USD 83.747%
Coya Therapeutics, Inc. -7.98 Million USD -22.824%
CNS Pharmaceuticals, Inc. -18.85 Million USD 47.956%
Galera Therapeutics, Inc. -59.08 Million USD 83.394%
Evelo Biosciences, Inc. -114.52 Million USD 91.433%
Comera Life Sciences Holdings, Inc. -18.37 Million USD 46.615%
Dominari Holdings Inc. -22.88 Million USD 57.124%
Edesa Biotech, Inc. -8.37 Million USD -17.154%
vTv Therapeutics Inc. -20.25 Million USD 51.551%
Bio-Techne Corporation 168.1 Million USD 105.836%
Agios Pharmaceuticals, Inc. -352.08 Million USD 97.213%
Harmony Biosciences Holdings, Inc. 128.85 Million USD 107.614%
Prelude Therapeutics Incorporated -121.83 Million USD 91.947%
Candel Therapeutics, Inc. -37.93 Million USD 74.14%
iTeos Therapeutics, Inc. -112.64 Million USD 91.29%
Nkarta, Inc. -117.5 Million USD 91.65%
BioCardia, Inc. -11.57 Million USD 15.21%
Iterum Therapeutics plc -38.37 Million USD 74.431%